OGX5-28

N/A

Report date: 2022/08/24 20:00:31

NME

Base Information

Drug NameOGX5-28

Drug Alias NameN/A

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionSclerostin inhibitors

TargetsSclerostin

Therapy Area/IndicationsOsteoporosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesOsteoGeneX Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesOsteoGeneX Inc

Active IndicationsN/A

Inactive IndicationsOsteoporosis

ATC CodeN/A